Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Transition to IFRS reporting, financial information communication, and Annual General Meeting in 2018

In its financial statements for 2017, Nixu Corporation will start following the International Financial Reporting Standards (IFRS) as part of the previously announced possible transition to the Nasdaq Helsinki stock exchange list.Nixu CorporationPress release, December 18, 2017 at 9:30 AM EET Transition to IFRS reporting, financial information communication, and Annual General Meeting in 2018 In its financial statements for 2017, Nixu Corporation will start following the International Financial Reporting Standards (IFRS) as part of the previously announced possible transition to the

Raisio plc: Announcement of conveyance of own shares

Raisio plc        Stock Exchange Release, 18 December 2017 ANNOUNCEMENT OF CONVEYANCE OF OWN SHARES In March 2017, Raisio plc’s Annual General Meeting decided that of the monthly reward of the Chairman and members of the Board, approximately 20% shall be paid by distributing shares held by the company and approximately 80% in cash. Rewards shall be paid in two equal lots during the term in June and in December. Raisio plc has assigned a total of 5,592 free shares (RAIVV) on December 18, 2017 (other conveyance) as a reward to the Chairman and members of the Board for their managing

Viking Supply Ships AB (publ) Interim report Q3 2017

Press release 18 December 2017Third quarter · Total revenue from continuing operations was MSEK 93 (235) · EBITDA from continuing operations was MSEK -18 (85) · Result after tax including discontinued operations was MSEK -99 (-93) · Result after tax per share including discontinued operations was SEK -0.3 (-0.5) Year to date · Total revenue from continuing operations was MSEK 264 (685) · EBITDA from continuing operations was MSEK -124 (212) · Result after tax including discontinued operations was MSEK -200 (-261) · Result after tax per share including

Cxense partners with Dow Jones to develop joint offering for WSJ’s biggest ad customers

Oslo, Norway – 18 December 2017 – Cxense ASA (OSE: CXENSE) today announced a partnership with Dow Jones to develop and market products based on Cxense’s data management and personalization software to The Wall Street Journal’s biggest advertisers. The new partnership follows the success in subscriber conversion with WSJ.com’s award-winning dynamic paywall powered by Cxense.  The Wall Street Journal will leverage Cxense’s DMP and personalization solution, including the Conversion Engine, to personalize custom content, as well as advertisements both on WSJ.com and clients’ web sites.

Immunovia initiates the world’s largest study of new onset diabetic patients in a prospective pancreas cancer study supported by SWElife

Sample collection providing access of up to 6 000 new onset diabetic patients is based on a collaboration including Sweden´s two major universities Lund and Uppsala, Lund University Diabetic Center, as well as Skåne and Uppsala healthcare regions.LUND, Sweden – Immunova AB today announced the initiation of PanDIA-1, the world´s largest prospective study of the new onset diabetes (“NOD”) risk group for pancreatic cancer through a consortium with Lund and Uppsala Universities, Lund University Diabetes Center and Healthcare Region Skåne and Region Uppsala. The consortium will receive a 7.6

Press release; Senzime receives CE mark approval for the OnZurf Probe

Uppsala, December 18, 2017. Senzime AB (publ) announces that the company has received CE mark approval for the OnZurf Probe, which means that the product now is approved for sale on the European market.OnZurf Probe will now be launched in Europe, initially by direct sales in Scandinavia, while other distribution agreements are established in the rest of Europe. OnZurf Probe is intended to be used after various surgical procedures on the gastrointestinal tract. "Continuous sampling in patients undergoing surgery may provide an opportunity to detect early complications. The clinical market

Fiskars Corporation – Notification of management’s transactions

Fiskars CorporationManagers’ transactionsDecember 18, 2017 at 09:30 EET Fiskars Corporation – Notification of management’s transactionsFiskars Corporation has received the following notification pursuant to Article 19 of the Market Abuse Regulation: Person subject to the notification requirementName: Tuominen Jaana  Position: Chief Executive Officer     Initial Notification  Reference number: 743700BKTW4EQIVKYY42_20171215143405_2

Quit smoking, nicotine free: R-kioski to distribute Acetium® lozenge in Finland

Biohit Oyj, Press release, December 18, 2017 at 9:30 am local time (EET) Biohit Oyj and R-kioski Oy have signed an agreement for the distribution of the smoking cessation product, Acetium lozenge in Finland. The contract is a non-exclusive distribution agreement. Launch date for the product will be announced later. The new Acetium lozenge is an effective and safe product that helps quit smoking without nicotine. Acetium lozenge has no side effects and its efficacy has been confirmed in clinical trials. Acetium lozenge eliminates cigarette smoke-derived carcinogenic acetaldehyde in the

SolunoBC offers enhanced options for conference and speaker phones

Two of Konftel’s hybrid phones have been validated for the SolunoBC cloud switchboard. This marks the start of a collaborative partnership between Konftel , a global leader in conference and speaker phones, and SolunoBC, a rapidly-expanding supplier of communication services to Swedish companies.The validation means that two popular Konftel phones have been tested and evaluated to determine their compatibility with the MiCloud Telepo-based switchboard service Soluno. The Konftel 300IPx is an IP telephone that can be used with the Konftel Unite app for simple and

Specim’s hyperspectral camera detects counterfeit medicine and traces of blood

Specim Oy, a VTT spin-off, has developed the world's first mobile hyperspectral camera for the fast, high-level analysis of a range of samples. VTT Technical Research Centre of Finland contributed its own expertise to the development project, in the form of fast measurement data processing algorithms and methods. The extremely high-precision hyperspectral camera, which resembles a normal digicamera, recognises materials and their differences from an image and provides results immediately on-site. Such information can be used to detect plant diseases, skin diseases, counterfeit art, faults

Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock, Inc ownership in Valmet decreased to below 5 percent

Valmet Oyj's stock exchange release on December 18, 2017 at 9:15 a.m. EET Valmet Oyj has on December 15, 2017 received a notification referred to in Securities Market Act from BlackRock, Inc, stating that the company's ownership and share of votes in Valmet Oyj has fallen below the threshold of 5 percent. As a result of share transactions on December 14, 2017, the holding of BlackRock, Inc decreased to below 5 percent of Valmet Oyj's total number of shares and share of votes. Valmet Oyj has one series of shares in which each share carries one vote. The aggregate number of shares is

Aker Solutions Wins Orders From Aker BP For Offshore Norway Fields

December 18, 2017 - Aker Solutions won orders from Aker BP for the Skogul and Valhall Flank West oil fields offshore Norway. The company will deliver two subsea manifolds, a controls system and umbilicals for Skogul, which will be tied back to the North Sea Alvheim field. It will also provide umbilicals and detailed engineering of the topside for a normally unmanned installation (NUI) for Valhall Flank West, which will be tied back to the Valhall field center. The subsea work will be carried out as part of Aker Solutions' subsea alliance with Aker BP and Subsea 7. The topside

Nico Delvaux appointed new President and CEO of ASSA ABLOY

The Board of Directors of ASSA ABLOY AB has appointed Nico Delvaux as the new President and CEO of ASSA ABLOY AB, effective June 18, 2018 at the latest. He will replace Johan Molin, who will leave his position after twelve successful years as CEO of ASSA ABLOY. “With Nico Delvaux, we have found a strong and experienced leader of large global businesses with a strong track record. He has managed complex and decentralized organizations and he has strong focus on innovation,” said Lars Renström, Chairman of ASSA ABLOY’s Board of Directors. “ASSA ABLOY has made a fantastic journey since the

Kemppi opens up a Robotic Welding Application Center in China

In order to strengthen its robotic welding business and speed up the growth in Asia, Kemppi opens up a robotic welding application center in China. The center provides complete and innovative solutions and services to the integrators and end customers. Kemppi’s experienced welding engineers help the customers to optimize their welding applications, and offer comprehensive training covering all aspects of welding. “Robotic welding and Asia are both strategic focus areas for Kemppi. Kemppi had its first deliveries to China already at the end of 1980s and has invested significantly in

Zaplox Reinforces and Expands Management Team with Newly Appointed Chief Technical Officer and Chief Marketing Officer

Zaplox AB (publ) (“Zaplox”), a market innovator of mobile key services for the global hotel industry, has strengthened its management team with the appointment of two C-level executives to newly created positions. Hotel technology industry veteran Eric Michélsen has been tapped as chief technical officer (CTO) and Pernilla Brodd has been named chief marketing officer (CMO), with both officially joining the company as of December 2017.Zaplox has continued to expand its organization over the past 12 months in order to align with its stated 2017 growth plan and the rapid pace of the company’s

OX2 and Aquila Capital in major deal for 357 MW wind farm in Sweden

OX2 announced today that the financing of Valhalla project comprising 85 wind turbines has been successfully completed. Aquila Capital will acquire the project which OX2 will deliver as an EPC contract.  It will be one of the largest onshore wind farms in Europe.The wind farm will be built in the municipalities of Bollnäs and Ockelbo, in central Sweden. The permits for the park have been developed in cooperation between OX2 and Bergvik Skog. Roman Rosslenbroich, CEO and Co-Founder of Aquila Capital says: “Wind energy investments in the Nordics region are highly attractive investments and

Schörling & Partners announces the result of the offer to the shareholders of MSAB

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States of America, or any other jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law.On 14 November

Telia Company acquires the Finnish ICT company Inmics Oy

Telia Company acquires 100 percent of Inmics Oy, a Finnish ICT company with a strong regional presence, at an enterprise value of EUR 75 million on a cash and debt free basis. The transaction will further strengthen Telia Company’s product portfolio with a competitive offer of IT equipment and services targeting the Finnish SME segment.   Inmics was founded in 1989 and has approximately 190 employees. The company is positioned as a local ICT-partner and acts as a reseller of workstations, IT-equipment and software and related managed services. Based on the 2016/17 results, the purchase

New dates for financial reports 2018

Serneke announces the following new dates for the release of its financial reports in 2018:· February 7: Year-end report 2017 · May 3: Interim report January-March 2018 · July 17: Interim report January-June 2018 (unchanged) · October 24: Interim report January-September 2018 The Annual General Meeting is held on May 3. For additional information, please contact:Anders Düring, CFOTel: +46 712 97 61anders.during@serneke.se This information is such that Serneke is required to disclose under the EU Market Abuse Regulation. The information was submitted under the

FDA accepts Tagrisso submission for 1st-line nsclc

18 December 2017 07:00 GMT US FDA ACCEPTS REGULATORY SUBMISSION FOR TAGRISSO IN 1ST-LINE EGFR-MUTATED NON-SMALL CELL LUNG CANCER Acceptance follows FDA Breakthrough Therapy Designation   Tagrisso granted Priority Review AstraZeneca today announced that the US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for the use of Tagrisso (osimertinib), a third-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with clinical activity against central nervous system (CNS) metastases, in the 1st-line

Flagging notification in accordance with Chapter 9 Section 10 othe Finnish Securities Markets Act

Basware Corporation, stock exchange release, Dec 18, 2017 at 9.00amFlagging notification in accordance with Chapter 9 Section 10 of the Finnish Securities Markets ActNotice pursuant to the Finnish Securities Market Act (Section 9:5): The total number of shares represented by Credit Suisse AG has decreased below 5% of Basware Corporation’s share capital and voting rights on Dec 14, 2017. This notification has been given to Basware Corporation's information on Dec 15, 2017.The holding of Credit Suisse AG after the disclosure:  +-------------------------------------+------+------------

Kværner ASA: Kvaerner awarded contract for Valhall Flank West

18 December 2017 - Today, Aker BP has awarded Kvaerner a contract for delivery of the topside and steel jacket substructure for Valhall Flank West. This is the first project in the Wellhead Platform Alliance, which was established in the spring of 2017 between Aker BP, Kvaerner, ABB and Aker Solutions. The contract for the normally unmanned platform represents a breakthrough in Kvaerner's strategy for  smaller platforms. The contract has a value of close to NOK 1 billion for Kvaerner. In April 2017 Kvaerner signed a frame agreement with Aker BP, and later an alliance agreement was signed

ICA Real Estate and Secore Fastigheter acquire 23 properties from KPA Pension

ICA Real Estate is buying eight store properties with an underlying property value of SEK 234 million, and Secore Fastigheter is buying 15 store properties with an underlying property value of SEK 291 million. The seller is KPA Pension. ICA stores are the main tenants of the properties, and possession will be transferred on 1 February 2018.“This acquisition is in line with ICA Real Estate’s long-term strategy to develop marketplaces with major development potential. The deal is also in line with Secore Fastigheter’s strategy to secure long-term ownership of marketplaces at which ICA is the

Targovax announces that TG02 has passed the initial safety review in the first-in-man clinical trial in colorectal cancer

Oslo, Norway, 18 December 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces that TG02 has passed the initial planned safety review in the phase Ib clinical mechanism-of-action trial evaluating TG02, and TG02 in combination with the checkpoint inhibitor KEYTRUDA® (pembrolizumab), in patients with confirmed RAS-mutated colorectal cancer. The safety review was carried out on the initial three patients enrolled in the first cohort, who are treated with TG02 as monotherapy. No issues were reported,

There are no items matching the current filter
There are no more items matching the current filter
Back to top